Skip to main content
. Author manuscript; available in PMC: 2014 Oct 23.
Published in final edited form as: Mol Pharm. 2011 Apr 22;8(3):788–798. doi: 10.1021/mp100393j

Figure 11.

Figure 11

Transfection efficiencies of TAT/DNA and 50% TAT-PEG-LABL/DNA complexes in activated A549 cells (overexpressing ICAM-1) after incubation with free LABL peptide or anti-ICAM-1 mAb prior to exposure to TAT complexes. Complexes were formed at an N/P ratio of 30 and 150 mM CaCl2. (* = p<0.05, ** = p<0.01, one-way ANOVA, Tukey post test).